April 26, 2017 — A new report on the brain cancer diagnostics market projects that up to 78,000 new cases of primary brain tumors are expected to be diagnosed globally in 2017, with approximately 25,000 found to be malignant.1 As research into precision medicine continues, both patients and healthcare professionals are anticipating greater use of this type of healthcare model in the diagnosis and treatment of brain tumors.
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now